eyeforpharma Awards: Recognizing and celebrating innovation

At the eyeforpharma Awards we strive to reward, support and incentivise innovation, especially when it comes to the value pharma offers patients and customers. We only recognize meaningful innovation which takes our industry, our reputation and our impact forward and the entries are measured objectively by external judges.  I was amazed by the quality of entries this year. With 500 nominations, our judges – a mixture of patients and health professionals – deliberated hard for many hours, finally settling on just 16 winners, each exemplifying the very best work in pharma.   By ‘best’, we mean not just internal successes (like revenue or ROI), but real impact on patients, carers and international health systems.  This is the night of the year when I feel most proud to work in this industry – the range and quality of solutions shows we can make a real difference. Every finalist has pushed us as an industry into a better place.   Huge congratulations to everyone.  The winners are: Most Valuable Healthcare/HCP Initiative   BioMarin Reaching target physicians globally with a high-quality, in-depth educational message about a rare disease was the challenge BioMarin faced when it set out to educate HCPs around the world about MPS (mucopolysaccharide) disorders. It used Figure 1, a mobile app tht healthcare professionals use to share cases to improve patient outcomes. Together with Dr. Chris Hendriksz, a pediatrician and well-regarded expert in MPS, they coll...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news